title: Neuroleptic malignant syndrome following combination of sertraline and paroxetine: a case report.
abstract: Neuroleptic malignant syndrome (NMS) is a rarely observed life-threatening medical condition due mostly to antipsychotic use. Additionally, a few case reports have suggested an association between NMS and the use of selective serotonin reuptake inhibitors (SSRIs) alone or in combination with antipsychotics. This case report presents a female patient developing NMS following the use of a combination of sertraline and paroxetine.
authors: Department of Psychiatry, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey. farukuguz@gmail.com
authors: Faruk
authors: F
authors: Uguz
authors: Erdem Önder
authors: EÖ
authors: Sonmez
mesh_terms: D003866:Depressive Disorder / Q000188:drug therapy*; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005260:Female; D006801:Humans; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D017374:Paroxetine / Q000009:adverse effects*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D020280:Sertraline / Q000009:adverse effects*
chemical_list: D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline